Report : Europe Airway Management Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Infraglottic Devices (Endotracheal Tubes, Tracheostomy Tubes, and Others), Supraglottic Devices, Laryngoscopes, Resuscitators, and Others] and End User (Hospitals, Ambulatory Surgical Care Centers, and Others)
At 7.0% CAGR, the Europe Airway Management Devices Market is speculated to be worth US$ 762.14 million by 2028, says Business Market Insights
According to Business Market Insights' research, the Europe airway management devices market was valued at US$ 508.81 million in 2022 and is expected to reach US$ 762.14 million by 2028, registering a CAGR of 7.0% from 2022 to 2028. New product launches and approvals and boosting prevalence of respiratory disorders are the key factors driving the market growth.
The increasing prevalence of various chronic disorders, such as asthma, COPD, cystic fibrosis, and emphysema, among a large population has fueled new product developments, product launches, and approvals on a global level. Additionally, major market players are involved in research and development activities to ensure the innovation and development of efficient products. Some of the recent product launches and developments are, in July 2022, Verathon announced the release of the BFlex 2.8 Single-use Bronchoscope. BFlex single-use bronchoscopes are designed specifically for the critical needs of the ICU, OR, and ED. The BFlex 2.8 is Verathon's first single-use pediatric bronchoscope and delivers the drivability and image quality needed for pediatric bronchoscopies, airway management, and lung isolation procedures. Further, in May 2021, Medtronic launched the SonarMed airway monitoring system to continuously check any endotracheal tube (ETT) obstruction and position for neonates and infants. It is the first and only device of its kind. The SonarMed airway monitoring system utilizes acoustic technology to check for ETT obstruction and verify position in real-time, giving clinicians vital information required to make more informed, life-saving decisions for their patients. Similarly, In May 2021, VivaSight 2 DLT was launched by Ambu. It is a sterile, single-use double-lumen endobronchial tube that isolates the left or right lung of a patient in one lung ventilation (OLV) procedures.
Thus, an increase in product development, launches and approvals is likely to drive the airway management devices market in the near future.
On the contrary, rise in product recalls and lack of reimbursement policies may act as restraining factors.
Based on product, the Europe airway management devices market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The Infraglottic Devices segment held 37.6% market share in 2022, amassing US$ 191.34 million. It is projected to garner US$ 285.42 million by 2028 to expand at 6.9% CAGR during 2022-2028.
Based on end user, the Europe airway management devices market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held 75.3% market share in 2022, amassing US$ 383.24 million. It is projected to garner US$ 573.74 million by 2028 to expand at 7.0% CAGR during 2022-2028.
Based on country, the Europe airway management devices market has been segmented into Germany, France, the UK, Italy, Spain, and Rest of Europe. Our regional analysis states that Rest of Europe captured 28.4% market share in 2022. It was assessed at US$ 144.16 million in 2022 and is likely to hit US$ 1,353.47 million by 2028, exhibiting a CAGR of 6.8% during the forecast period.
Key players dominating the Europe airway management devices market are Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; ARMSTRONG MEDICAL; and Cook Medical LLC among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com